R&D Advantage Report: Key Productivity Metrics for R&D
April 1, 2020
Building on its long history of measuring R&D performance, KMR creates this new flagship report built from its own proprietary research and methods to provide senior management at companies of all sizes with access to key performance indicators in BioPharma R&D. The report is designed for companies of all sizes but especially for small to mid-cap biopharma that have limited data of their own but who are looking for a trusted and reliable resource for benchmarking data that can be used for goal setting and understanding how different approaches to R&D are impacting productivity. This is a high level assessment examining cycle time, success rates, productivity, and value.